Celularity (CELU) Revenue (2020 - 2025)

Celularity (CELU) has reported Revenue for 6 consecutive years, with $4.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Revenue rose 496.51% year-over-year to $4.1 million in Q4 2025; TTM through Dec 2025 was $26.6 million, a 27.81% decrease from a year earlier, with the FY2025 full-year figure at $26.6 million, down 51.03% from the prior year.
• Revenue was $4.1 million for Q4 2025 at Celularity, down from $5.3 million in the prior quarter.
• Over five years, Revenue peaked at $14.7 million in Q1 2024 and troughed at $688000.0 in Q4 2024.
• A 5-year average of $6.3 million and a median of $4.5 million in 2021 frame the typical range for Revenue.
• Across the five-year window, Revenue plunged 94.32% in 2024 and jumped 496.51% in 2025, its largest moves.
• Over 5 years, Revenue stood at $4.9 million in 2021, then dropped by 14.97% to $4.1 million in 2022, then soared by 193.34% to $12.1 million in 2023, then sank by 94.32% to $688000.0 in 2024, then jumped by 496.51% to $4.1 million in 2025.
• The last three Revenue figures came in at $4.1 million (Q4 2025), $5.3 million (Q3 2025), and $5.7 million (Q2 2025), per Business Quant data.